Venturi Wealth Management’s Novartis NVS Stock Holding History

Venturi Wealth Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.68M	Buy	17,084 +581	+4%	+$87.1K	0.1%	105
2026 Q1	$2.52M	Buy	16,503 +1,425	+9%	+$218K	0.11%	105
2025 Q4	$2.08M	Buy	15,078 +1,510	+11%	+$198K	0.09%	120
2025 Q3	$1.74M	Buy	13,568 +611	+5%	+$74.6K	0.08%	133
2025 Q2	$1.57M	Buy	12,957 +1,081	+9%	+$122K	0.08%	149
2025 Q1	$1.32M	Buy	11,876 +245	+2%	+$26.1K	0.07%	168
2024 Q4	$1.13M	Buy	11,631 +5,983	+106%	+$638K	0.06%	192
2024 Q3	$650K	Buy	5,648 +27	+0.5%	+$3.06K	0.03%	248
2024 Q2	$598K	Buy	5,621 +43	+0.8%	+$4.32K	0.04%	252
2024 Q1	$540K	Sell	5,578 -13	-0.2%	-$1.33K	0.03%	258
2023 Q4	$565K	Sell	5,591 -31	-0.6%	-$2.99K	0.04%	247
2023 Q3	$573K	Buy	5,622 +3,439	+158%	+$349K	0.05%	225
2023 Q2	$220K	Sell	2,183 -8	-0.4%	-$800	0.02%	292
2023 Q1	$202K	Sell	2,191 -1,129	-34%	-$98.6K	0.02%	317
2022 Q4	$301K	Buy	3,320 +177	+6%	+$14.9K	0.03%	278
2022 Q3	$239K	Sell	3,143 -725	-19%	-$60.1K	0.02%	291
2022 Q2	$327K	Sell	3,868 -1,008	-21%	-$88.4K	0.03%	262
2022 Q1	$428K	Buy	4,876 +273	+6%	+$23.6K	0.03%	255
2021 Q4	$403K	Sell	4,603 -255	-5%	-$21.2K	0.03%	263
2021 Q3	$397K	Sell	4,858 -960	-17%	-$86.4K	0.03%	251
2021 Q2	$531K	Sell	5,818 -1,964	-25%	-$175K	0.05%	229
2021 Q1	$665K	Sell	7,782 -459	-6%	-$41.2K	0.06%	205
2020 Q4	$778K	Buy	8,241 +1,386	+20%	+$121K	0.08%	171
2020 Q3	$596K	Buy	6,855 +2,152	+46%	+$186K	0.07%	188
2020 Q2	$411K	Buy	4,703 +1,488	+46%	+$128K	0.06%	203
2020 Q1	$265K	Buy	3,215 +574	+22%	+$51.2K	0.05%	190
2019 Q4	$250K	Sell	2,641 -254	-9%	-$22.8K	0.03%	217
2019 Q3	$252K	Sell	2,895 -413	-12%	-$37.1K	0.03%	209
2019 Q2	$302K	Sell	3,308 -5,629	-63%	-$476K	0.04%	200
2019 Q1	$767K	Sell	8,937 -364	-4%	-$29.2K	0.1%	120
2018 Q4	$706K	Buy	+9,301	New	+$724K	0.11%	115
2018 Q1	–	Sell	-2,803	Closed	-$211K	–	186
2017 Q4	$211K	Buy	2,803 +183	+7%	+$13.8K	0.04%	187
2017 Q3	$203K	Buy	+2,620	New	+$198K	0.04%	181

Other funds holding NVS

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

GGI

Godsey & Gibb Inc Richmond, Virginia $1.22B AUM 27.93% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

MIM

Martin Investment Management Palm Beach Gardens, Florida $300M AUM 6.05% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

BCAM

Boston Common Asset Management Boston, Massachusetts $1.69B AUM 28.29% 1-Year Est. Return

MGIA

Matthew Goff Investment Advisor Houston, Texas $593M AUM 28.9% 1-Year Est. Return

Venturi Wealth Management's NVS Position: Q2 2026 in Review

Venturi Wealth Management increased its Novartis (NVS) stake by 3.5% in Q2 2026, buying an estimated $87.1K and bringing the position to 17,084 shares worth $2.68M. The position accounts for 0.1% of the portfolio, ranked #105.

Venturi Wealth Management first reported a position in NVS in Q3 2017 and has held it in 33 quarters since. 406 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Venturi Wealth Management held 17,084 shares of Novartis worth $2.68M as of Q2 2026.
Venturi Wealth Management bought 581 Novartis shares in Q2 2026, an estimated $87.1K.
Novartis made up 0.1% of Venturi Wealth Management's portfolio in Q2 2026, its #105 holding.
Venturi Wealth Management first reported a position in Novartis in Q3 2017 and has held it in 33 quarters since.
406 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Venturi Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.